A Study of Rituximab in Combination With Fludarabine and Cyclophosphamide in Participants With Chronic Lymphocytic Leukemia and Favorable Somatic Status

Mise à jour : Il y a 4 ans
Référence : NCT01271010

Femme et Homme

Extrait

This multi-center, single-arm study will evaluate the efficacy and safety of rituximab in combination with fludarabine and cyclophosphamide in participants with B-cell chronic lymphocytic leukemia (CLL) and favorable somatic status.


Critère d'inclusion

  • Lymphocytic Leukemia, Chronic

Liens